What did the two top-performing biotech stocks last week have in common? As you might expect, and as today’s article notes, “They both delivered positive press releases regarding their respective coronavirus vaccine candidates.” After having surged by 219% and 108%, respectively, are either of these two biotechs buys – or are they better avoided? For more, CLICK HERE.